Mirus Bio

Mirus Bio company information, Employees & Contact Information

Explore related pages

Related company profiles:

OUR MISSION: Deliver Innovation. Empower Discovery. Improve Life. For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Our work is both technical and cutting-edge, and we promote a culture of creativity, responsibility, and respect. Our team members are engaged and motivated by the desire to support our customers and partners to achieve strong results. Mirus, together with MilliporeSigma, the life science arm of Merck KGaA, Darmstadt, Germany, is establishing the future of science and medicine by developing products that enable product developers within the cell and gene therapy space. As we approach a new era of addressing and conquering life-altering diseases, we will continue to expand our expertise and leadership in transfection to be integral in the future of advanced therapies.

Company Details

Employees
62
Founded
-
Address
5602 Research Park Blvd,
Phone
6084412849
Email
in****@****bio.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Madison, WI
Looking for a particular Mirus Bio employee's phone or email?

Mirus Bio Questions

News

Transfection: Past, Present, and Future - BioProcess International

Transfection: Past, Present, and Future BioProcess International

Mirus Bio Receives ISO 13485:2016 Certification - PR Newswire

Mirus Bio Receives ISO 13485:2016 Certification PR Newswire

UW biotech spinoff Mirus Bio celebrates two decades in business - University of Wisconsin–Madison

UW biotech spinoff Mirus Bio celebrates two decades in business University of Wisconsin–Madison

MilliporeSigma boosts its gene therapy manufacturing capability with $600M acquisition of Mirus Bio - Fierce Pharma

MilliporeSigma boosts its gene therapy manufacturing capability with $600M acquisition of Mirus Bio Fierce Pharma

Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering - Merck Group

Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering Merck Group

Increased Transfection Efficiency Boosts AAV Titers for Gene Therapies by 2–4X - Genetic Engineering and Biotechnology News

Increased Transfection Efficiency Boosts AAV Titers for Gene Therapies by 2–4X Genetic Engineering and Biotechnology News

Protocol for optimizing surface expression and speed in coaggregation assays using K562 cells and subsequent analysis with a CoAg Index - ScienceDirect.com

Protocol for optimizing surface expression and speed in coaggregation assays using K562 cells and subsequent analysis with a CoAg Index ScienceDirect.com

Gamma Biosciences Launches Initiative Through Mirus Bio to Develop Lipid-Polymer Nanocomplexes for In Vivo mRNA Delivery - PR Newswire

Gamma Biosciences Launches Initiative Through Mirus Bio to Develop Lipid-Polymer Nanocomplexes for In Vivo mRNA Delivery PR Newswire

Advertorial: Mirus Bio - Genetic Engineering and Biotechnology News

Advertorial: Mirus Bio Genetic Engineering and Biotechnology News

Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines - PR Newswire

Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines PR Newswire

Mirus Bio Launches RevIT™ AAV Enhancer - PR Newswire

Mirus Bio Launches RevIT™ AAV Enhancer PR Newswire

Transient Transfection of Suspension Cells - Genetic Engineering and Biotechnology News

Transient Transfection of Suspension Cells Genetic Engineering and Biotechnology News

Top Mirus Bio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant